Teandra Darden
Nurse Practitioner · Fort Worth, TXNPI 1295369387
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 44.9% of the total. Reporting peaked in 2022 at $3,019 and has fallen 71.3% since, to $867 in 2023. Among nurse practitioner clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $23.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Amgen$848
- Johnson & Johnson$521
- Janssen Scientific Affairs, LLC$254
- Novartis$222
- UCB, Inc.$173
- plus $648 from 12 others
What the payments were for
- Food & beverage$4,72698%
- Education$1152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 90 | $2,175 |
| Amgen(2 entities) | 26 | $848 |
| Johnson & Johnson | 22 | $521 |
| Janssen Scientific Affairs, LLC | 3 | $254 |
| Novartis | 22 | $222 |
| UCB, Inc. | 9 | $173 |
| Pfizer | 8 | $134 |
| AstraZeneca(2 entities) | 5 | $113 |
| Aurinia Pharma U.S., Inc. | 3 | $69 |
| Organon | 8 | $63 |
| Sanofi-aventis U.S. LLC | 1 | $60 |
| Lilly USA, LLC | 3 | $59 |
| Hikma Pharmaceuticals USA | 2 | $47 |
| Actelion Pharmaceuticals US, Inc. | 1 | $31 |
| GSK | 1 | $22 |
| Tersera Therapeutics LLC | 1 | $19 |
| Medtronic | 1 | $16 |
| Sandoz | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,841 in reported general payments places this provider in the 90th percentile of 5,422 nurse practitioner providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 11 | $270 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Fort Worth
- Deborah StapelFort Worth$44K
- Jessica RothFort Worth$15K
- Kathryn MorelandFort Worth$15K
- Cecilia DavisAustin$262K
- Melanie MorrisHouston$254K
- Stephanie BrownHarlingen$235K
- Brittney MisercolaKilleen$223K
- Roger ChapmanTyler$211K
- Corrie BerkSan Antonio$155K
- Samantha OnealDallas$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.